3-(Cyclopentyloxy)-4-methoxybenzaldehyde - CAS 67387-76-2
Catalog: |
BB033268 |
Product Name: |
3-(Cyclopentyloxy)-4-methoxybenzaldehyde |
CAS: |
67387-76-2 |
Synonyms: |
3-cyclopentyloxy-4-methoxybenzaldehyde; 3-cyclopentyloxy-4-methoxybenzaldehyde |
IUPAC Name: | 3-cyclopentyloxy-4-methoxybenzaldehyde |
Description: | 3-(Cyclopentyloxy)-4-methoxybenzaldehyde (CAS# 67387-76-2) is a useful research chemical. |
Molecular Weight: | 220.26 |
Molecular Formula: | C13H16O3 |
Canonical SMILES: | COC1=C(C=C(C=C1)C=O)OC2CCCC2 |
InChI: | InChI=1S/C13H16O3/c1-15-12-7-6-10(9-14)8-13(12)16-11-4-2-3-5-11/h6-9,11H,2-5H2,1H3 |
InChI Key: | FZFWPURYSWKIRT-UHFFFAOYSA-N |
Boiling Point: | 351.9 °C at 760 mmHg |
Density: | 1.136 g/cm3 |
Appearance: | Powder |
LogP: | 2.82910 |
GHS Hazard Statement: | H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]; H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]; H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H335 (100%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation] |
Precautionary Statement: | P261, P264, P264+P265, P270, P271, P280, P301+P316, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
RU-2670097-C1 | Substituted 4-aryl-hexahydro-7h-imidazolo[1,5-b][1,2]oxazine-7-ones and method for production thereof | 20180525 |
CA-3027097-A1 | Bicyclic fused pyrazole derivatives for the treatment of rsv | 20160510 |
EP-3454897-A1 | Bicyclic fused pyrazole derivatives for the treatment of rsv | 20160510 |
US-2019144441-A1 | Bicyclic fused pyrazole derivatives for the treatment of rsv | 20160510 |
WO-2017196982-A1 | Bicyclic fused pyrazole derivatives for the treatment of rsv | 20160510 |
PMID | Publication Date | Title | Journal |
21649644 | 20111201 | GEBR-7b, a novel PDE4D selective inhibitor that improves memory in rodents at non-emetic doses | British journal of pharmacology |
14987986 | 20040301 | Synthesis and biological evaluation of neutrophilic inflammation inhibitors | Farmaco (Societa chimica italiana : 1989) |
Complexity: | 223 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 220.109944368 |
Formal Charge: | 0 |
Heavy Atom Count: | 16 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 220.109944368 |
Rotatable Bond Count: | 4 |
Topological Polar Surface Area: | 35.5 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2.6 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Customers Also Viewed
-
[1271-47-2]
Ethynylferrocene
-
[433335-00-3]
N-Boc-(tosyl)methylamine
-
[1808-26-0]
Ethyl arachidonate
-
[132182-92-4]
Pentane, 1,1,1,2,2,3,4,5,5,5-decafluoro-3-methoxy-4-(trifluoromethyl)-
-
[79551-14-7]
Ferene Disodium Salt
-
[119-24-4]
Folic Acid EP Impurity D (Methotrexate EP Impurity D)
INDUSTRY LEADERS TRUST OUR PRODUCTS